mepacrine hydrochloride
mepacrine hydrochloride.JPG

CLINICAL USE

Giardiasis Discoid lupus erythematosus

DOSE IN NORMAL RENAL FUNCTION

100 mg every 8 hours for 5–7 days

PHARMACOKINETICS

  • Molecular weight                           :508.9
  • %Protein binding                           :80–90
  • %Excreted unchanged in urine     : <11
  • Volume of distribution (L/kg)       :Large
  • half-life – normal/ESRD (hrs)      :5–14 days

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in normal renal function
  • HD                     :Unlikely to be dialysed. Dose as in normal renal function
  • HDF/high flux   :Unlikely to be dialysed. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Alcohol: can cause a mild disulfiram reaction
  • Antimalarials: increased concentration of primaquine (increased risk of toxicity)

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    OTHER INFORMATION

    Still detectable in the urine after 2 months



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs